Abatacept s.c. for aGVHD Prevention in Haplo-HCT

Clinical trial NCT04686929 · COMPLETED

Trial details

NCT number: NCT04686929
Sponsor: The First Affiliated Hospital of Soochow University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Abatacept Acute-graft-versus-host Disease Haplo-identical HCT Prevention

Start date: 2021-06-01
Primary completion: 2023-05-31
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.